Overview: Fraud detection, radiology, and retention analytics carry the strongest proof.Vendor claims shrink in neutral tests ...
Biotech Insider News Commentary - For most of the past decade, the promise of AI in drug discovery was measured in designs: more candidate molecules, generated faster.
Partnership applies Deep Origin's virtual screening architecture to BioAge's targets, identified from human data, to ...
Strategic partnerships, splicing modulators and non-coding RNA targets offer high-potential routes into oncology, rare disease and CNS therapiesDublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "RNA Targeting ...
University of Washington researchers built Prompteina, the first model generating 3D protein structures from plain-English ...
Curi Bio Expands the Curiverseâ„¢ with New Disease Models, Casting Kits, and Application-Ready Solutions ...
AI is accelerating antibiotic discovery, but clinical translation requires standardized data, safety optimization, and new ...
Growing demand for anti-obesity drugs in India has positioned the country as a research and manufacturing hub for global ...
Strategic outsourcing, AI, automation and integrated CRO partnerships boost discovery speed, scalability, cost control and customer retention.Dublin, Oct. (GLOBE NEWSWIRE) -- "Drug Discovery Services ...
TDB-DST signs agreement with Peptris to accelerate AI-driven drug discovery and development: Our Bureau, Mumbai Tuesday, October 13, 2026, 13:30 Hrs [IST] In a significant step to ...
Bengaluru-based Peptris Technologies secures ₹86 crore RDI support for the preclinical development of innovative ...
Key Points of This Discussion】Distinguish between the discovery of exendin-4 and the development of drugs that act on the GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results